Segui
Luca Pastorelli
Luca Pastorelli
università di milano, case western reserve university, university of virginia
Email verificata su unimi.it
Titolo
Citata da
Citata da
Anno
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics
L Pastorelli, C De Salvo, JR Mercado, M Vecchi, TT Pizarro
Frontiers in immunology 4, 280, 2013
4882013
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
L Pastorelli, RR Garg, SB Hoang, L Spina, B Mattioli, M Scarpa, C Fiocchi, ...
Proceedings of the National Academy of Sciences 107 (17), 8017-8022, 2010
4792010
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ...
Gut 69 (7), 1213-1217, 2020
3442020
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives
GE Tontini, M Vecchi, L Pastorelli, MF Neurath, H Neumann
World journal of gastroenterology: WJG 21 (1), 21, 2015
2572015
SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis
TT Pizarro, L Pastorelli, G Bamias, RR Garg, BK Reuter, JR Mercado, ...
Inflammatory bowel diseases 17 (12), 2566-2584, 2011
1962011
IL-33 activates tumor stroma to promote intestinal polyposis
RL Maywald, SK Doerner, L Pastorelli, C De Salvo, SM Benton, ...
Proceedings of the National Academy of Sciences 112 (19), E2487-E2496, 2015
1732015
Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism
D Corridoni, L Pastorelli, B Mattioli, S Locovei, D Ishikawa, KO Arseneau, ...
PloS one 7 (7), e42067, 2012
1282012
Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease
A Latiano, O Palmieri, L Pastorelli, M Vecchi, TT Pizarro, F Bossa, G Merla, ...
PloS one 8 (4), e62144, 2013
1122013
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
LR Lopetuso, C De Salvo, L Pastorelli, N Rana, HN Senkfor, V Petito, ...
Proceedings of the National Academy of Sciences 115 (40), E9362-E9370, 2018
992018
Neurological disorders and inflammatory bowel diseases
G Casella, GE Tontini, G Bassotti, L Pastorelli, V Villanacci, L Spina, ...
World Journal of Gastroenterology: WJG 20 (27), 8764, 2014
902014
The role of IL-33 in gut mucosal inflammation
L Pastorelli, C De Salvo, M Vecchi, TT Pizarro
Mediators of inflammation 2013, 2013
822013
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised …
L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ...
The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022
722022
A consumer’s guide for probiotics: 10 golden rules for a correct use
M Toscano, R De Grandi, L Pastorelli, M Vecchi, L Drago
Digestive and Liver Disease 49 (11), 1177-1184, 2017
722017
IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis
C De Salvo, XM Wang, L Pastorelli, B Mattioli, S Omenetti, KA Buela, ...
The American Journal of Pathology 186 (4), 885-898, 2016
652016
Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease
M Severs, SJH van Erp, ME Van Der Valk, MJJ Mangen, HH Fidder, ...
Journal of Crohn's and Colitis 10 (4), 455-461, 2016
642016
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
S Danese, JF Colombel, M Lukas, JP Gisbert, G d'Haens, B Hayee, ...
The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022
632022
Microscopic colitis: what do we know about pathogenesis?
LF Pisani, GE Tontini, M Vecchi, L Pastorelli
Inflammatory bowel diseases 22 (2), 450-458, 2016
632016
Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation
L Pastorelli, C De Salvo, MA Cominelli, M Vecchi, TT Pizarro
Therapeutic advances in gastroenterology 4 (5), 311-323, 2011
602011
Challenges in the care of IBD patients during the CoViD-19 pandemic: report from a “Red Zone” area in Northern Italy
V Occhipinti, L Pastorelli
Inflammatory bowel diseases 26 (6), 793-796, 2020
592020
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical …
X Gui, A Bazarova, R Del Amor, M Vieth, G De Hertogh, V Villanacci, ...
Gut 71 (5), 889-898, 2022
582022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20